Accelerate Diagnostics reported $-17170000 in EBITDA for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Abbott ABT:US USD 2.5B 703M
Becton, Dickinson and BDX:US USD 1.28B 100M
Bio Rad Laboratories BIO:US USD 130.1M 22.72M
Bruker BRKR:US USD 153.9M 44.8M
Danaher DHR:US USD 2.56B 202M
Exact Sciences EXAS:US USD -83543000 17.59M
Hologic HOLX:US USD 286.8M 61.1M
Illumina ILMN:US USD 349M 225M
Meridian Bioscience VIVO:US USD 13.03M 435K
Myriad Genetics MYGN:US USD -31900000 27.1M
Thermo Fisher Scientific TMO:US USD 2.58B 280M